Federal contractor · public award history
AVKARE LLC
Parent: AVKARE LLC UGC4CXE71LM4
- Awards we know about
- 26
- Typical size
- $763,431
- Middle of their public awards
- Dollars on those awards
- $763,431
Most of their awards we can see fall roughly between $763,431 and $763,431.
SAM.gov registration
Public extract 2026-07-05
- Status
- Active
- Purpose of registration
- All awards (Z2)
- Registration expires
- Feb 12, 2027
- Activation date
- Feb 12, 2026
- Primary NAICS (SAM)
- 325412
Business types (SAM)
Registration fields from the official SAM.gov public entity extract (monthly bulk). Not a substitute for live SAM checks.
From official USAspending contract records — not a capability rating, past-performance score, or recommendation to team or bid.
Awarding agencies
- Department of Veterans Affairs (26)
Industries & product codes
Award history
- Department of Veterans Affairs—
65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
- Department of Veterans Affairs—
3 LINE ITEMS FOR FAMCICLOVIR TABLETS. AWARDED FOR A BASE YEAR OF 9/27/2021 TO 9/26/2022 PLUS FOUR ONE-YEAR OPTION PERIODS.
- Department of Veterans Affairs—
NEW AWARD FOR VARDENAFIL HCL TABLETS WITH AVKARE. PERFORMANCE PERIOD IS AUGUST 7, 2022 - AUGUST 6, 2023 WITH FOUR ONE-YEAR OPTIONS
- Department of Veterans Affairs—
NEW AWARD FOR PIROXICAM CAPSULES WITH AVKARE. PERIOD OF PERFORMANCE IS 8/12/2021 - 8/11/2022 WITH FOUR ONE-YEAR OPTIONS
- Department of Veterans Affairs—
NEW AWARD FOR ACETAZOLAMIDE TABLETS WITH AVKARE. ORDERING PERIOD IS JULY 31, 2022 TO JULY 30, 2023 WITH FOUR ONE-YEAR OPTIONS
- Department of Veterans Affairs—
NEW AWARD FOR VENLAFAXINE WITH AVKARE. PERIOD OF PERFORMANCE IS 8/30/2021 - 8/29/2022 WITH FOUR ONE-YEAR OPTIONS
- Department of Veterans Affairs—
NEW AWARD FOR EMTRICITABINE 200MG/TENOFOVIR DISOPROXIL FUMARATE 300MG TABLETS WITH AVKARE, LLC. BASE YEAR ORDERING PERIOD IS OCTOBER 6, 2025 TO OCTOBER 5, 2026 WITH FOUR ONE-YEAR OPTIONS.
- Department of Veterans Affairs—
AWARD TO AVKARE, LLC FOR MONTELUKAST HCL CHEWABLE TABLETS BASE YEAR WITH FOUR ONE YEAR OPTIONS. BASE YEAR EFFECTIVE 8/9/2021 - 8/8/2022.
- Department of Veterans Affairs—
NEW AWARD FOR 36E79724D0029 TO AVKARE, LLC. FOR BASE YEAR AND 4 ONE-YEAR OPTION PERIODS.
- Department of Veterans Affairs—
NEW AWARD FOR CARBIDOPA/LEVODOPA IT TABELETS WITH AVKARE, LLC. PERIOD OF PERFORMANCE IS 6/21/2021 - 6/20/2022 WITH FOUR ONE-YEAR OPTIONS.
- Department of Veterans Affairs—
NEW AWARD FOR MYCOPHENOLATE MOFETIL CAPSULES AND TABLETS WITH AVKARE. PERIOD OF PERFORMANCE 6/23/2025 - 6/22/2026
- Department of Veterans Affairs—
AWARD TO AVKARE LLC FOR ABIRATERONE TABLETS FOR THE BASE YEAR WITH FOUR ONE YEAR OPTIONS.
- Department of Veterans Affairs—
5 LINE ITEMS FOR OXYBUTYNIN TABLETS. AWARDED FOR A BASE YEAR AND 4 ONE-YEAR OPTION PERIODS.
- Department of Veterans Affairs—
NEW AWARD FOR ASPIRIN 25 MG/DIPYRIDAMOLE 200MG SUSTAINED ACTION (SA) CAPSULES WITH AVKARE LLC. BASE YEAR ORDERING PERIOD IS MAY 14, 2025 - MAY 13, 2026 WITH FOUR ONE-YEAR OPTIONS.
- Department of Veterans Affairs—
NEW AWARD FOR TADALAFIL TABLETS WITH AVKARE, INC. PERIOD OF PERFORMANCE IS MARCH 16, 2020 THROUGH MARCH 15, 2021 WITH FOUR ONE YEAR OPTIONS.
- Department of Veterans Affairs—
NEW AWARD FOR FLUDROCORTISONE ACETATE TABLETS WITH AVKARE, LLC. PERIOD OF PERFORMANCE IS OCTOBER 26, 2020 THROUGH OCTOBER 25, 2021 WITH FOUR ONE YEAR OPTIONS.
- Department of Veterans Affairs—
VALGANCICLOVIR HCL TABLETS
- Department of Veterans Affairs—
NEW AWARD FOR LAMOTRIGINE WITH AVKARE. PERIOD OF PERFORMANCE IS 03/16/2020 TO 03/15/2021.
- Department of Veterans Affairs—
NEW AWARD FOR ACITRETIN CAPSULES WITH AVKARE. ORDERING PERIOD IS 12/11/2022 - 12/10/2023 WITH FOUR ONE-YEAR OPTIONS.
- Department of Veterans Affairs—
AWARD FOR ASPIRIN 25MG/DIPYRIDAMOLE 200MG CAPSULE, SA FOR BASE YEAR WITH FOUR ONE YEAR OPTIONS. PERIOD OF PERFORMANCE IS FROM 4/6/2020 - 4/5/2021.
- Department of Veterans Affairs—
AWARD FOR CYCLOBENZAPRINE HCL 10MG TABLETS FOR BASE YEAR WITH FOUR ONE YEAR OPTIONS. EFFECTIVE 5/15/2020 - 5/14/2021
- Department of Veterans Affairs—
AWARD FOR CLOBETASOL PROPIONATE CREAM AND OINTMENT FOR BASE YEAR WITH FOUR ONE YEAR OPTIONS. PERIOD OF PERFORMANCE IS 8/11/2020 THROUGH 8/10/2021
- Department of Veterans Affairs—
NEW AWARD FOR RANOLAZINE SA TABLETS WITH AVKARE, LLC. PERIOD OF PERFORMANCE IS 11/20/2020 THROUGH 11/19/2021 WITH FOUR ONE-YEAR OPTIONS.
- Department of Veterans Affairs—
NEW AWARD FOR VERAPAMIL IR TABLETS WITH AVKARE, LLC PERIOD OF PERFORMANCE IS JUNE 1, 2020 - MAY 31, 2021 WITH FOUR ONE-YEAR OPTIONS.
- Department of Veterans Affairs—
NEW AWARD FOR TERIFLUNOMIDE TABLETS WITH AVKARE LLC. PERIOD OF PERFORMANCE IS DEC 23, 2023 TO DEC 22, 2024 WITH FOUR ONE-YEAR OPTIONS.
- Department of Veterans Affairs$763,431
PHARMACEUTICALS 770-25-1-801-0018 -NATIONAL CMOP METFORMIN HCL
Intelligence only — not legal advice, not a past-performance evaluation, and not a recommendation to team or bid. Verify on USAspending and SAM.gov.